CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.15

EPS Forecast

$4.04

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Market expectations

EPS Expectation:

-$1.15

Revenue Expectation:

$4.04

EPS Surprise Expectation:

-$0.004

Revenue Surprise Expectation:

-$3

Post-release price volatility - High

Post-release Overnight Move:

±7.7%

Post-release 1-week Move:

±

Expected price impact

If company results match EPS & revs consensus exactly:

1.3%

If company results match Proximilar expectations exactly:

0.5%

Earnings volatility

EPS standard deviation:

$0.28

Revenue standard deviation:

$12

As % of share price:

0.59% VERY HIGH

As % of market cap:

0.27% LOW